Skip to search formSkip to main contentSkip to account menu
Technology evaluation: APC-80200, Dendreon.
  • Alison Rice, D. Hart
  • Medicine, Biology
    Current opinion in molecular therapeutics
  • 1 October 2002
TLDR
This vaccine candidate appears to be of particular benefit in patients who have received high-dose chemotherapy to reduce tumor load following stem cell rescue, and is also being tested in patients with amyloidosis.
View on PubMed
"Dechiffrer le silence": A Conversation with Germaine Tillion
View via Publisher
Development of mutagenically-separated PCR assays for equine genetic screening
"Dechiffrer le silence": A Conversation with Germaine
?Dchiffrer le silence?: A Conversation with Germaine Tillion
View via Publisher
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License